Predictors of Loss to Follow-Up in an HIV Vaccine Preparedness Study in Masaka, Uganda

被引:2
|
作者
Kabarambi, Anita [1 ,2 ]
Kansiime, Sheila [1 ,2 ,3 ]
Kusemererwa, Sylvia [1 ,2 ]
Kitonsa, Jonathan [1 ,2 ]
Kaleebu, Pontiano [1 ,2 ,3 ]
Ruzagira, Eugene [1 ,2 ,3 ]
机构
[1] Uganda Virus Res Inst, Med Res Council, POB 49, Entebbe, Uganda
[2] London Sch Hyg & Trop Med, Med Uganda Res Unit, POB 49, Entebbe, Uganda
[3] London Sch Hyg & Trop Med, London WC1E 7HT, England
关键词
HIV prevention; loss to follow up; HIV vaccine studies; high-risk; Uganda; COHORT; RETENTION; TRIALS; RISK; SEX;
D O I
10.3390/ijerph19116377
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Background: High participant retention is essential to achieve adequate statistical power for clinical trials. We assessed participant retention and predictors of loss to follow-up (LTFU) in an HIV vaccine-preparedness study in Masaka, Uganda. Methods: Between July 2018 and March 2021, HIV sero-negative adults (18-45 years) at high risk of HIV infection were identified through HIV counselling and testing (HCT) from sex-work hotspots along the trans-African highway and fishing communities along the shores of Lake Victoria. Study procedures included collection of baseline socio-demographic data, quarterly HCT, and 6-monthly collection of sexual risk behaviour data. Retention strategies included collection of detailed locator data, short clinic visits (1-2 h), flexible reimbursement for transport costs, immediate (<= 7 days) follow-up of missed visits via phone and/or home visits, and community engagement meetings. LTFU was defined as missing >= 2 sequential study visits. Poisson regression models were used to identify baseline factors associated with LTFU. Results: 672 participants were included in this analysis. Of these, 336 (50%) were female and 390 (58%) were <= 24 years. The median follow-up time was 11 months (range: 0-31 months). A total 214 (32%) participants were LTFU over 607.8 person-years of observation (PYO), a rate of 35.2/100 PYO. LTFU was higher in younger participants (18-24 years versus 35-45 years, adjusted rate ratio (aRR) = 1.29, 95% confidence interval (CI) 0.80-2.11), although this difference was not significant. Female sex (aRR = 2.07, 95% CI, 1.51-2.84), and recreational drug use (aRR = 1.61, 95% CI, 1.12-2.34) were significantly associated with increased LTFU. Engagement in transactional sex was associated with increased LTFU (aRR = 1.36, 95% CI, 0.97-1.90) but this difference was not significant. LTFU was higher in 2020-2021 (the period of COVID-19 restrictions) compared to 2018-2019 (aRR = 1.54, 1.17-2.03). Being Muslim or other (aRR = 0.68, 95% CI 0.47-0.97) and self-identification as a sex worker (aRR = 0.47, 95% CI, 0.31-0.72) were associated with reduced LTFU. Conclusion: We observed a high LTFU rate in this cohort. LTFU was highest among women, younger persons, recreational drug users, and persons who engage in transactional sex. Efforts to design retention strategies should focus on these subpopulations.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Recruitment of participants into an HIV vaccine preparedness study: experiences from Masaka, Uganda
    Asio, D. J.
    Nabukenya, S.
    Kusemererwa, S.
    Okello, J. Mugisha
    Ruzagira, E.
    Kaleebu, P.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2021, 24
  • [2] Community engagement and volunteer recruitment experiences in a HIV vaccine preparedness study in Masaka, Uganda
    Masawi, S.
    Nabukenya, S.
    Mugisha, J.
    Kitonsa, J.
    Nakamanya, S.
    Kabarambi, A.
    Kusemererwa, S.
    Ruzagira, E.
    Kaleebu, P.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2021, 24
  • [3] Retention of adults from fishing communities in an HIV vaccine preparedness study in Masaka, Uganda
    Bahemuka, Ubaldo Mushabe
    Abaasa, Andrew
    Ruzagira, Eugene
    Lindan, Christina
    Price, Matt A.
    Kamali, Anatoli
    Fast, Pat
    PLOS ONE, 2019, 14 (01):
  • [4] HIV Incidence and Risk Factors for Acquisition in HIV Discordant Couples in Masaka, Uganda: An HIV Vaccine Preparedness Study
    Ruzagira, Eugene
    Wandiembe, Symon
    Abaasa, Andrew
    Bwanika, Agnes N.
    Bahemuka, Ubaldo
    Amornkul, Pauli
    Price, Matthew A.
    Grosskurth, Heiner
    Kamali, Anatoli
    PLOS ONE, 2011, 6 (08):
  • [5] Prevalence and Incidence of HIV in a Rural Community-Based HIV Vaccine Preparedness Cohort in Masaka, Uganda
    Ruzagira, Eugene
    Wandiembe, Symon
    Abaasa, Andrew
    Levin, Jonathan
    Bwanika, Agnes
    Bahemuka, Ubaldo
    Price, Matthew A.
    Kamali, Anatoli
    PLOS ONE, 2011, 6 (06):
  • [6] Predictors of oral pre-exposure prophylaxis (PrEP) uptake among individuals in a HIV vaccine preparedness cohort in Masaka, Uganda
    Kusemererwa, Sylvia
    Kansiime, Sheila
    Mutonyi, Gertrude
    Namirembe, Aeron
    Katana, Safina
    Kitonsa, Jonathan
    Kakande, Ayoub
    Okello, Joseph Mugisha
    Kaleebu, Pontiano
    Ruzagira, Eugene
    MEDICINE, 2021, 100 (44)
  • [7] Determinants of loss to follow-up among HIV positive patients receiving antiretroviral therapy in a test and treat setting: A retrospective cohort study in Masaka, Uganda
    Kiwanuka, Julius
    Waila, Jacinta Mukulu
    Kahungu, Methuselah Muhindo
    Kitonsa, Jonathan
    Kiwanuka, Noah
    PLOS ONE, 2020, 15 (04):
  • [8] Predictors of loss to follow-up from HIV antiretroviral therapy in Namibia
    Hong, Steven Y.
    Winston, Anna
    Mutenda, Nicholus
    Hamunime, Ndapewa
    Roy, Tuhin
    Wanke, Christine
    Tang, Alice M.
    Jordan, Michael R.
    PLOS ONE, 2022, 17 (04):
  • [9] Estimation and predictors of loss to follow-up in transgender women living with HIV: A multicenter observational study
    De Vito, A.
    Giacomelli, A.
    Mazzitelli, M.
    Cossu, M. V.
    Colpani, A.
    Cervo, A.
    Ciccullo, A.
    Colombo, M. L.
    Moschese, D.
    Pozza, G.
    Sportoletti, S.
    Caloni, B.
    Agostini, E.
    Lagi, F.
    Formica, G.
    Menozzi, M.
    Fabbiani, M.
    Morcos, J.
    Cattelan, A.
    Baldin, G.
    Madeddu, G.
    HIV MEDICINE, 2023, 24 : 599 - 601
  • [10] Predictors of loss to follow-up before HIV treatment initiation in Northwest Ethiopia: a case control study
    Ahmed, Ismael
    Gugsa, Salem T.
    Lemma, Seblewengel
    Demissie, Meaza
    BMC PUBLIC HEALTH, 2013, 13